SARS-CoV-2 Variants, Vaccines, and Host Immunity P Mistry, F Barmania, J Mellet, K Peta, A Strydom, IM Viljoen, ... Frontiers in Immunology 12 (809244), 2022 | 266 | 2022 |
Contact tracing during the COVID-19 pandemic: Protection of personal information in South Africa C De Villebois Castelyn, M Botes, IM Viljoen, A Pope, MS Pepper South African Journal of Bioethics and Law 13 (1), 20-25, 2020 | 14 | 2020 |
Open access and its potential impact on public health–A South African perspective A Strydom, J Mellet, J Van Rensburg, IM Viljoen, A Athanasiadis, ... Frontiers Media, 2022 | 11 | 2022 |
Resource allocation during COVID-19: A focus on vulnerable populations CV Castelyn, IM Viljoen, A Dhai, MS Pepper South African Journal of Bioethics and Law 13 (2), 83-86, 2020 | 10 | 2020 |
Perspectives on establishing a public cord blood inventory in South Africa IM Viljoen, CL Hendricks, J Mellet, MS Pepper Cytotherapy 23 (6), 548-557, 2021 | 6 | 2021 |
Regenerative medicines: A new regulatory paradigm for South Africa IM Viljoen, CL Hendricks, HL Malherbe, MS Pepper Biochimie 196, 123-130, 2022 | 2 | 2022 |
When cells become medicines: A South African perspective IM Viljoen, MS Pepper South African Medical Journal 111 (11), 1055 - 1059, 2021 | 2 | 2021 |